EU Tenders

Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening

Title in Dutch as published on TED.

Call for competition published on TED on 29 May 2026 by Ziekenhuis aan de Stroom vzw (ZAS) (Belgium), CPV 33652000 Antineoplastic and immunomodulating agents.

Notice368381-2026 (cn-standard)
StatusClosed tender
Published29 May 2026
BuyerZiekenhuis aan de Stroom vzw (ZAS), Antwerpen
CountryBelgium
Main CPV33652000-5 Antineoplastic and immunomodulating agents
Contract typesupplies
Procedureopen
Estimated valueEUR 2,300,000 excl. VAT
Deadline for tenders1 Jul 2026 10:00

Daily EU tender alerts

Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.

Open on TED Tender documents

Description

Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening

Lots (1)

LotTitleEstimated valueDeadline
LOT-0001Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toedieningEUR 2,300,0001 Jul 2026

More Antineoplastic and immunomodulating agents in Belgium

Raamovereenkomst voor de levering van Tocilizumab
Award · Pharmaceutical products · 2 Nov 2026 · Belgium · Hospilim VZW · value EUR 577,755 · won by Celltrion Healthcare Netherlands B.V.
Raamovereenkomst voor het leveren van Kort- en langwerkende GCSF (granulocyt-kolonie-stimulerende factoren)
Tender · General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents · 29 Oct 2026 · Belgium · Hospilim VZW · deadline 27 Nov 2026
Leveren van Pomalidomide - capsule 1 mg; 2 mg; 3 mg; 4 mg
Award · Antineoplastic and immunomodulating agents · 14 Oct 2026 · Belgium · UZ Leuven
Raamovereenkomst voor de levering van cytostatica
Award · Pharmaceutical products · 18 Sep 2026 · Belgium · Hospilim VZW · value EUR 17,135,728 · won by Fresenius Kabi, ACCORD HEALTHCARE
Rituximab
Award · Antineoplastic agents · 19 Aug 2026 · Belgium · Cliniques universitaires Saint Luc · value EUR 628,800 · won by Celltrion Healthcare Netherlands B.V.
Infliximab
Award · Antineoplastic and immunomodulating agents · 19 Aug 2026 · Belgium · Cliniques universitaires Saint Luc · value EUR 2,492,000 · won by Celltrion Healthcare Netherlands B.V.

All 11 notices

Get new antineoplastic and immunomodulating agents tenders by email

A free weekly digest of new competition notices from TED. One-click unsubscribe in every email.

A manager will help with your first launch.

Daily EU tender alerts

Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.